47.73.Z - Retail sale of pharmaceutical products
20.42.Z - Manufacture of cosmetics and toilet preparations
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.74.Z - Retail sale of medical and orthopedic products
47.75.Z - Retail sale of cosmetics and toiletries
73.11.Z - Advertising agency activities
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 1,7 | 1,7 | 1,9 | 16,1 |
EBITDA | 1,7 | 1,7 | 2 | 13,7 |
Short time liabilities | 1,1 | 2,6 | 2,5 | -5,4 |
Equity capital | 10,7 | 12,1 | 13,8 | 14,7 |
Operating profit (EBIT) | 1,7 | 1,7 | 1,9 | 16,1 |
Assets | 11,7 | 14,7 | 16,3 | 11,1 |
Net profit (loss) | 1,7 | 1,7 | 1,9 | 16,1 |
Cash | 0,9 | 1 | 1 | -0,6 |
Net income from sale | 14,2 | 14,2 | 18,3 | 28,4 |
Liabilities and provisions for liabilities | 1,1 | 2,6 | 2,5 | -5,4 |
Working assets | 11,6 | 14,6 | 16,2 | 11,4 |
Depreciation | 0,1 | 0,1 | 0 | -36,6 |
% | % | % | p.p. | |
Profitability of capital | 15,5 | 13,7 | 13,9 | 0,2 |
Equity capital to total assets | 91 | 82 | 84,7 | 2,7 |
Gross profit margin | 11,6 | 11,6 | 10,5 | -1,1 |
EBITDA Margin | 12,2 | 12,2 | 10,8 | -1,4 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 27 | 68 | 50 | -18 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane